logo
  • We are an evolutionary engineering firm
    We do small things in a big way with synthetic biology.
  • What We Do.
    By using synthetic biology we mimic what happens via Natural Selection. This biomimicry approach enables us to leverage millions of years of "prototyping" by natural selection. This speeds us forward in our areas of expertise; namely water, foods, fuels, chemicals, therapeutics, and materials.
  • Genetics Rights Management (GeRM)
    Each BactoBot™ strain is developed with its own unique genetics rights management (GeRM) consumable key system. If the low cost, commodity priced molecular keys are not present in the feedstock, the BactoBots™ self destruct. The GeRM system is similar to digital rights management (DRM) used by the software and content industries to protect their digital assets. GeRM enables us to ship synthetic biology knowledge and consumable keys, not genetically modified organisms (GMO). In addition to protecting BactoBots against theft and environmental release, GeRM system enables an economic development platform for creating home-grown synthetic biology industries.

    For more information about the GeRM value proposition, please watch this SHORT VIDEO.
  • Case Study: Pilus Energy subsidiary
    Our first subsidiary, Pilus Energy, was acquired via a reverse triangular merger by Tauriga Sciences, Inc. (OTCQB: TAUG) in January, 2014. Pilus Energy is focused on deploying its BactoBot in an electrogenic bioreactor to clean industrial customer wastewater. In conjunction with cleaning the wastewater, the BactoBots metabolically transform the organic waste molecules in values such as direct electrical current and chemical products. This wastewater-to-value proposition provides industrial and municipal customers a substantial revenue-generating and cost-saving opportunity while cleaning the wastewater. The BactoBots being used by Tauriga Sciences’ is also protected by its own consumable and commodity-priced GeRM keys.

A global biotechnology firm, Microbial Robotics (formerly Bacterial Robotics) develops synthetic biology products using patented and proprietary technologies.  The Company develops enhanced bacteria (BactoBots™) and viruses (ViruBots™).  These organism-based “bots” produce, build, sense, and perform functions for the water, energy, chemical, and pharmaceutical industries.  When a BactoBot™ or ViruBot™ is developed, its proof-of-concept, product development plan, and intellectual property is placed into a subsidiary.  That subsidiary gains an acquiring market expert for productization and commercialization.

The Company's biotechnology products are protected by a consumable genetics rights management (GeRM™) system.  The GeRM system is a consumable additive that prevents theft or release.